Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001873082-25-000003·InCube Labs, L.L.C.
Schedule 13D ownership disclosure
RANI THERAPEUTICS HLDGS INC
Class A Common Stock, par value $0.0001 per share · CUSIP: 753018100
Event date: 2025-10-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- InCube Labs, L.L.C.Reported CIK 0001873082
Shares: 22,424,788.00 · Class: 18.7%
- MIR A IMRANReported CIK 0001031686
Shares: 27,093,552.00 · Class: 22.1%
- InCube Ventures II, LP
Shares: 301,710.00 · Class: 0.3%
- Rani Investment Corp.
Shares: 7,694.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001873082-25-000003
- Form type
- SCHEDULE 13D/A
- Filer
- InCube Labs, L.L.C.
- CIK
- CIK 1873082
- Filed
- Oct 27, 2025
- Reporting period
- Oct 23, 2025
- Description
- Schedule 13D beneficial ownership